Literature DB >> 33864033

Human TRIM14 protects transgenic mice from influenza A viral infection without activation of other innate immunity pathways.

Valentina V Nenasheva1, Natalia A Nikitenko2, Ekaterina A Stepanenko3, Irina V Makarova3, Lyudmila E Andreeva3, Galina V Kovaleva3, Andrey A Lysenko2, Amir I Tukhvatulin2, Denis Y Logunov2, Vyacheslav Z Tarantul3.   

Abstract

TRIM14 is an important component of innate immunity that defends organism from various viruses. It was shown that TRIM14 restricted influenza A virus (IAV) infection in cell cultures in an interferon-independent manner. However, it remained unclear whether TRIM14 affects IAV reproduction and immune system responses upon IAV infection in vivo. In order to investigate the effects of TRIM14 at the organismal level we generated transgenic mice overexpressing human TRIM14 gene. We found that IAV reproduction was strongly inhibited in lungs of transgenic mice, resulting in the increased survival of transgenic animals. Strikingly, upon IAV infection, the transcription of genes encoding interferons, IL-6, IL-1β, and TNFα was notably weaker in lungs of transgenic animals than that in control mice, thus indicating the absence of significant induction of interferon and inflammatory responses. In spleen of transgenic mice, where TRIM14 was unexpectedly downregulated, upon IAV infection the transcription of genes encoding interferons was oppositely increased. Therefore, we demonstrated the key role of TRIM14 in anti-IAV protection in the model organism that is realized without noticeable activation of other innate immune system pathways.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33864033     DOI: 10.1038/s41435-021-00128-6

Source DB:  PubMed          Journal:  Genes Immun        ISSN: 1466-4879            Impact factor:   2.676


  42 in total

Review 1.  TRIM Family Proteins: Roles in Autophagy, Immunity, and Carcinogenesis.

Authors:  Shigetsugu Hatakeyama
Journal:  Trends Biochem Sci       Date:  2017-01-22       Impact factor: 13.807

Review 2.  The interplay between viruses and TRIM family proteins.

Authors:  Ramisha Khan; Amna Khan; Amjad Ali; Muhammad Idrees
Journal:  Rev Med Virol       Date:  2019-01-04       Impact factor: 6.989

Review 3.  TRIM Proteins and Their Roles in Antiviral Host Defenses.

Authors:  Michiel van Gent; Konstantin M J Sparrer; Michaela U Gack
Journal:  Annu Rev Virol       Date:  2018-06-27       Impact factor: 10.431

4.  Many Faces of TRIM Proteins on the Road from Pluripotency to Neurogenesis.

Authors:  Valentina V Nenasheva; Vyacheslav Z Tarantul
Journal:  Stem Cells Dev       Date:  2019-12-03       Impact factor: 3.272

5.  TRIM proteins and cancer.

Authors:  Shigetsugu Hatakeyama
Journal:  Nat Rev Cancer       Date:  2011-10-07       Impact factor: 60.716

Review 6.  TRIM family proteins and their emerging roles in innate immunity.

Authors:  Keiko Ozato; Dong-Mi Shin; Tsung-Hsien Chang; Herbert C Morse
Journal:  Nat Rev Immunol       Date:  2008-11       Impact factor: 53.106

7.  Interferon alpha (IFNα)-induced TRIM22 interrupts HCV replication by ubiquitinating NS5A.

Authors:  Chen Yang; Xinhao Zhao; Dakang Sun; Leilei Yang; Chang Chong; Yu Pan; Xiumei Chi; Yanhang Gao; Moli Wang; Xiaodong Shi; Haibo Sun; Juan Lv; Yuanda Gao; Jin Zhong; Junqi Niu; Bing Sun
Journal:  Cell Mol Immunol       Date:  2015-02-16       Impact factor: 11.530

Review 8.  TRIM family proteins: retroviral restriction and antiviral defence.

Authors:  Sébastien Nisole; Jonathan P Stoye; Ali Saïb
Journal:  Nat Rev Microbiol       Date:  2005-10       Impact factor: 60.633

9.  TRIM22 inhibits influenza A virus infection by targeting the viral nucleoprotein for degradation.

Authors:  Andrea Di Pietro; Anna Kajaste-Rudnitski; Alexandra Oteiza; Lucia Nicora; Greg J Towers; Nadir Mechti; Elisa Vicenzi
Journal:  J Virol       Date:  2013-02-13       Impact factor: 5.103

Review 10.  InTRIMsic immunity: Positive and negative regulation of immune signaling by tripartite motif proteins.

Authors:  Gijs A Versteeg; Stefan Benke; Adolfo García-Sastre; Ricardo Rajsbaum
Journal:  Cytokine Growth Factor Rev       Date:  2014-08-13       Impact factor: 7.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.